- Dec 17, 2023
Nivolumab Associated With Higher Survival in Pediatric Advanced-Stage Hodgkin Lymphoma
Replacing brentuximab vedotin with nivolumab in first-line treatment combined with the chemotherapy regimen AVD improved progression-free...
- Oct 31, 2023
Cranial Radiotherapy Predisposes Pediatric Cancer Survivors to Hypothyroidism
Hypothyroidism and hypogonadism are likely among cranial radiotherapy-treated survivors of childhood-onset acute lymphoblastic leukemia...
- Jun 29, 2023
Research shows fertility challenges for women treated for childhood Hodgkin lymphoma
The research also found that women treated for Hodgkin lymphoma may have to try for longer to become pregnant; however, the majority of ...
- Nov 4, 2022
Pediatric Multicenter Study Shows Targeted Therapy for High-Risk Hodgkin Lymphoma Reduces Relapse
Children with high-risk Hodgkin lymphoma were 10% less likely to relapse following treatment with brentuximab vedotin combination. Read...
- Jul 26, 2022
Cardiovascular disease, not cancer, top cause of death among Hodgkin lymphoma survivors
Patients with early-stage classic Hodgkin lymphoma and other neoplasms exhibited higher risk for cardiovascular disease-associated...
- Dec 7, 2020
Long-Term Survivors of Childhood Hodgkin Lymphoma at Increased Risk for Neurocognitive Impairment
"Despite receiving no neurotoxic therapy directed to the central nervous system, long-term survivors of childhood Hodgkin lymphoma (HL)...
- Dec 17, 2018
Survivors of childhood Hodgkin lymphoma face high long-term risk of solid cancers
New research refines existing evidence that survivors of childhood Hodgkin lymphoma face an elevated risk of developing various types of...
- Aug 29, 2016
Survivors of Hodgkin lymphoma face high cardiovascular toxicity burden
Cardiovascular toxicities occurred more frequently and severely among adult survivors of pediatric, adolescent and young adult Hodgkin...